The company in question is, Amgen Inc. (NASDAQ:AMGN) currently with a stock price of 171.38 (-0.91% today). The market cap for Amgen Inc. is 128706.38, and is in the sector Healthcare, and Biotechnology industry. The target price for Amgen Inc. is 190.56. Currently Amgen Inc. is trading with a P/E of 17.54, and a forward P/E of 13.74. Average volume for Amgen Inc. is 2953.48 and so far today it is 2225000.
Performance in the last year for Amgen Inc. has been 16.61%. For EPS growth, Amgen Inc. has seen a growth of 35.20%, and is looking to grow in the next year to 9.83%. More long term stats show that EPS growth has been 13.60% over the last five years and could be 7.93% for the next five years. Amgen Inc. has seen sales growth quarter over quarter at 5.90%, with EPS growth quarter over quarter at 14.90%. The 20-day simple moving average is 1.29%, with the 200-day simple moving average coming to 9.96%.
Since the IPO date for Amgen Inc. on the 9/7/1984, Amgen Inc. has seen performance year to date to be 7.63%. With Amgen Inc. trading at 171.38, the dividend yield is 2.33%, and the EPS is 9.77.
So could Amgen Inc., be undervalued? Well as said before P/E is 17.54. The PEG is 2.21, P/S is 5.73 and the P/B is at 4.27. The P/cash is 3.67, with P/free cash flow at 21.5.
Amgen Inc. ability to deal with debt shows that the current ratio is 4, and the quick ratio is 3.7. This is with long term debt/equity at 0.93, and total debt/equity at 1.1.
In terms of margins, Amgen Inc. has a gross margin of 81.40%, an operating margin of 40.70% and a profit margin of 33.10%.Payout ratio for Amgen Inc. is 36.30%. Return on assets come to 10.10% with return on investment coming to 12.50%.
Insider ownership for Amgen Inc., is at 0.20% and institutional ownership comes to 81.10%. Outstanding shares are at 751. While shares float is 747.47. The float short is currently 1.07%, and short ratio is 2.71.